FDA Drug Application (207620) for ENTRESTO by NOVARTIS PHARMS CORP

Back to FDA Applications sponsored by NOVARTIS PHARMS CORP

Application Number207620
Product Number001
FormTABLET;ORAL
Dosage24MG;26MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameENTRESTO
Active IngredientSACUBITRIL; VALSARTAN

Active IngredientCount
List of drugs with Active Ingredient VALSARTAN12


Back to FDA Applications sponsored by NOVARTIS PHARMS CORP